Strength
45 mg/1
Manufacturer
Astellas Pharma US, Inc.NDC
00469266030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/14/2026
Active Ingredients
FEZOLINETANTApproval Type
New Drug (NDA)
FDA Application
NDA216578On Market Since
5/12/2023
Pharmacological Classes
Neurokinin 3 Receptor Antagonist
Neurokinin 3 Receptor Antagonists
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.